Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 infection, admission and death among people with rare autoimmune rheumatic disease in England: results from the RECORDER project
Megan Rutter, Peter Lanyon, Matthew J. Grainge, et al.
Lara D. Veeken (2021) Vol. 61, Iss. 8, pp. 3161-3171
Open Access | Times Cited: 18

Showing 18 citing articles:

Disparities in COVID-19 mortality amongst the immunosuppressed: A systematic review and meta-analysis for enhanced disease surveillance
Meredith Leston, Willam Elson, José M. Ordóñez‐Mena, et al.
Journal of Infection (2024) Vol. 88, Iss. 3, pp. 106110-106110
Open Access | Times Cited: 19
COVID-19 multi-state epidemic forecast in India
Oleg Gaidai, Fang Wang, Vladimir Yakimov
DELETED (2023)
Open Access | Times Cited: 33
COVID-19 spatio-temporal forecast in England
Oleg Gaidai, Vladimir Yakimov, Fuxi Zhang
Biosystems (2023) Vol. 233, pp. 105035-105035
Closed Access | Times Cited: 25
COVID-19 Epidemic Forecast in Brazil
Oleg Gaidai, Yihan Xing
Bioinformatics and Biology Insights (2023) Vol. 17
Open Access | Times Cited: 23
Future worldwide coronavirus disease 2019 epidemic predictions by Gaidai multivariate risk evaluation method
Oleg Gaidai, Yu Cao, Yan Zhu, et al.
Analytical Science Advances (2024) Vol. 5, Iss. 7-8
Open Access | Times Cited: 9
Adherence to vaccination against SARS-CoV-2 and vaccine safety in patients with immunoglobulin G4-related disease
L. Mastromanno, Federico Giardina, Angelica Gattamelata, et al.
Reumatismo (2025)
Open Access
Prevalence and demographics of 331 rare diseases and associated COVID-19-related mortality among 58 million individuals: a nationwide retrospective observational study
Johan H. Thygesen, Huayu Zhang, Hanane Issa, et al.
The Lancet Digital Health (2025) Vol. 7, Iss. 2, pp. e145-e156
Closed Access
Evaluation of the UK's COVID-19 public health policy “Shielding: Results of a linked data matched cohort study
Helen Snooks, Ashley Akbari, L. Bethell, et al.
Public Health (2025) Vol. 244, pp. 105736-105736
Open Access
COVID-19 infection, admission and death and the impact of corticosteroids among people with rare autoimmune rheumatic disease during the second wave of COVID-19 in England: results from the RECORDER Project
Megan Rutter, Peter Lanyon, Matthew J. Grainge, et al.
Lara D. Veeken (2023) Vol. 62, Iss. 12, pp. 3828-3837
Open Access | Times Cited: 4
COVID-19 infection characteristics, risk factors and its potential impacts on Takayasu arteritis: a web-based survey in a large cohort
Xiufang Kong, Jinghua Wang, Guihua Fan, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 1
Will ‘the feeling of abandonment’ remain? Persisting impacts of the COVID-19 pandemic on rheumatology patients and clinicians
Melanie Sloan, Rupert Harwood, Caroline Gordon, et al.
Lara D. Veeken (2021) Vol. 61, Iss. 9, pp. 3723-3736
Open Access | Times Cited: 9
COVID-19 vaccine immunogenicity in 16 patients with autoimmune systemic diseases. Lack of both humoral and cellular response to booster dose and ongoing disease modifying therapies
Laura Gragnani, Marcella Visentini, Serena Lorini, et al.
Journal of Translational Autoimmunity (2022) Vol. 5, pp. 100164-100164
Open Access | Times Cited: 6
COVID-19 outcomes in patients with a history of immune-mediated glomerular diseases
Philipp Gauckler, Jana S. Kesenheimer, Duvuru Geetha, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Anti-SARS-CoV-2 antibodies following vaccination are associated with lymphocyte count and serum immunoglobulins in SLE
John A. Reynolds, Sian Faustini, Sofia Tosounidou, et al.
Lupus (2023) Vol. 32, Iss. 3, pp. 431-437
Open Access | Times Cited: 2
Rheumatoid arthritis and COVID-19: Three years later
Б. С. Белов, E. S. Aronova, Г. И. Гриднева, et al.
Rheumatology Science and Practice (2023) Vol. 61, Iss. 4, pp. 450-457
Open Access | Times Cited: 2
A nationwide study of 331 rare diseases among 58 million individuals: prevalence, demographics, and COVID-19 outcomes
Johan H. Thygesen, Huayu Zhang, Hanane Issa, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Antibody response to four doses of SARS-CoV-2 vaccine in rare autoimmune rheumatic diseases: an observational study
Leher Gumber, Hannah K Jackson, Nancy E. Gomez, et al.
Rheumatology Advances in Practice (2023) Vol. 7, Iss. 3
Open Access
A Multi-dimensional Reliability Method for Predicting the Future of COVID-19 in the World
Oleg Gaidai, Wang Kelin
(2022)
Open Access
A deeper dive into rare autoimmune diseases, death and COVID-19 in the first wave of the pandemic
Marwan Bukhari
Lara D. Veeken (2021) Vol. 61, Iss. 8, pp. 3095-3096
Open Access
Page 1

Scroll to top